SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-021189
Filing Date
2024-08-13
Accepted
2024-08-13 16:48:33
Documents
1
Period of Report
2024-08-12

Document Format Files

Seq Description Document Type Size
1 form4-08132024_080829.html 4  
1 form4-08132024_080829.xml 4 4334
  Complete submission text file 0001415889-24-021189.txt   5780
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Issuer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PASSAGE BIO, INC. 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103
Business Address
Forman Mark S (Reporting) CIK: 0001922353 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40928 | Film No.: 241202489